Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Cassandra Kinch"'
Autor:
Gerd R. Burmester, Laura C. Coates, Stanley B. Cohen, Yoshiya Tanaka, Ivana Vranic, Edward Nagy, Irina Lazariciu, All-shine Chen, Kenneth Kwok, Lara Fallon, Cassandra Kinch
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 5, Pp 1255-1276 (2023)
Abstract Introduction The safety of tofacitinib in psoriatic arthritis (PsA) and rheumatoid arthritis (RA) has been demonstrated in clinical studies of ≤ 4 and 9.5 years, respectively. Post-marketing surveillance (PMS) data for tofacitinib from spo
Externí odkaz:
https://doaj.org/article/34b105e8c7c24f45a0dae2316f33af1c
Autor:
Gerd R. Burmester, Laura C. Coates, Stanley B. Cohen, Yoshiya Tanaka, Ivana Vranic, Edward Nagy, Irina Lazariciu, All-shine Chen, Kenneth Kwok, Lara Fallon, Cassandra Kinch
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 1, Pp 221-222 (2023)
Externí odkaz:
https://doaj.org/article/099e14f76fec48319dad1e2044b6fc13
Autor:
Dafna D Gladman, Lihi Eder, Vibeke Strand, David Gruben, Alexis Ogdie, Ari Polachek, Philip Mease, Sibel Z Aydin, Cassandra Kinch, Remy A Pollock, Rayana Luna, Mary Jane Cadatal
Publikováno v:
RMD Open, Vol 9, Iss 1 (2023)
Background Evaluate the impact of sex on tofacitinib efficacy, safety and persistence (time to discontinuation) in patients with psoriatic arthritis (PsA).Methods Data were pooled from two phase 3 randomised controlled trials. Patients were randomise
Externí odkaz:
https://doaj.org/article/0eae573dacbc4459a2ce54a3fc3c13a1
Autor:
Xiaofeng Zeng, Cunshan Wang, Yi Liu, Jian Xu, Ju Liu, Zhuoli Zhang, Wenfeng Tan, Shengyun Liu, Wei Lin, Weiguo Wan, Zhenyu Jiang, Zhiyi Zhang, Oluwaseyi Dina, Shixue Liu, XiaoMei Leng, Keith Kanik, Jiankang Hu, Jingyang Li, Levent M. Gunay, Cassandra Kinch
Publikováno v:
RMD Open, Vol 9, Iss 1 (2023)
Objectives Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, were evaluated in a 6-month, double-blind, phase 3 study in Chinese patients with active (polyarthritic) psoriatic arthritis (PsA) and inadequate response to ≥1 conventi
Externí odkaz:
https://doaj.org/article/95e7525994d9450aa6a0ec678516e46f
Autor:
Louis Bessette, Cassandra Kinch
Publikováno v:
The Journal of rheumatology.
We thank Dr. Tchetina for their interest in our article
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b7bbd0cefc19bc6cbac77c8c62cc861
https://pubmed.ncbi.nlm.nih.gov/36243412
https://pubmed.ncbi.nlm.nih.gov/36243412
Autor:
Lihi Eder, Dafna D Gladman, Philip Mease, Remy A Pollock, Rayana Luna, Sibel Z Aydin, Alexis Ogdie, Ari Polachek, David Gruben, Mary Jane Cadatal, Cassandra Kinch, Vibeke Strand
Publikováno v:
RMD Open. 9:e002718
BackgroundEvaluate the impact of sex on tofacitinib efficacy, safety and persistence (time to discontinuation) in patients with psoriatic arthritis (PsA).MethodsData were pooled from two phase 3 randomised controlled trials. Patients were randomised
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ad8ff2c953e1fb3c0acb01f71f3c685
https://doi.org/10.1136/rmdopen-2022-002718
https://doi.org/10.1136/rmdopen-2022-002718
Autor:
Boulos, Haraoui, Majed, Khraishi, Denis, Choquette, Larissa, Lisnevskaia, Michelle, Teo, Cassandra, Kinch, Corina, Galos, Patrice, Roy, David, Gruben, John C, Woolcott, Julie, Vaillancourt, John S, Sampalis, Edward C, Keystone, Latha, Naik
Publikováno v:
Arthritis careresearchREFERENCES.
The Canadian Tofacitinib for Rheumatoid Arthritis Observational (CANTORAL) is the first Canadian prospective, observational study assessing tofacitinib. The objective was to assess effectiveness and safety for moderate to severe rheumatoid arthritis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c01322553dd48c2e1ff9821f654f917
https://pubmed.ncbi.nlm.nih.gov/35678771
https://pubmed.ncbi.nlm.nih.gov/35678771
Autor:
Xiaomei Leng, Wei Lin, Shixue Liu, Keith Kanik, Cunshan Wang, Weiguo Wan, Zhenyu Jiang, Yi Liu, Shengyun Liu, Zhuoli Zhang, Zhiyi Zhang, Jian Xu, Wenfeng Tan, Jiankang Hu, Jingyang Li, Ju Liu, Levent M. Gunay, Oluwaseyi Dina, Cassandra Kinch, Xiaofeng Zeng
Publikováno v:
RMD Open. 9:e002559
ObjectivesEfficacy and safety of tofacitinib, an oral Janus kinase inhibitor, were evaluated in a 6-month, double-blind, phase 3 study in Chinese patients with active (polyarthritic) psoriatic arthritis (PsA) and inadequate response to ≥1 conventio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70358f67d2924799b4b9f876cb68e616
https://doi.org/10.1136/rmdopen-2022-002559
https://doi.org/10.1136/rmdopen-2022-002559